ÂÜÀòÂÒÂ×

Joel Richard, PhD, HDR, currently serves as a Senior R&D Executive at DBV Technologies and as a Scientific Advisory Board Member at Ecole Nationale Supérieure de Chimie de Montpellier. Previously, Joel Richard held key leadership roles, including Chief Development Officer and Executive Committee Member at Enterome, and Chief Scientific Officer at MedinCell, where responsibilities encompassed leading research, development operations, and ensuring compliance throughout clinical phases. Prior experience includes significant positions at Ipsen in Pharmaceutical Development for peptides and small molecules, and at Merck Serono and Serono in pharmaceutical development for biotech products. Educational qualifications include degrees from esteemed institutions such as Ecole Normale Supérieure - Cachan and University Paris VI, culminating in expertise in Physics, Chemistry, and Materials Science.